BackSeelos Therapeutics Overview

Seelos Therapeutics Operating Income

Operating Income for SEEL.

Quarterly Operating Income

$-3139000.00
↓ 71.34% YoY

As of Jun 30, 2024

Annual Operating Income (TTM)

$-29807999.00
↓ 46.34% YoY

Trailing 12 months ending Jun 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin